SNDY Presents Another Stunning Opportunity For Near Term Gain Potential
Good Afternoon!
Solos Endoscopy, Inc. (OTCPINK: SNDY)
SNDY has delivered for us before and I believe that the current chart formation allows for some serious gain potential.
SNDY is continuing its bullish run and is now up +600% on its 12-month low of .0030. The near term upside potential is strong and with a RSI of 37 you can see easily why I believe this is the bounce opportunity of opportunities for May.
Right now entry is very accessible .0220 and volatility levels are just screaming for traders to take action.
Make your move now and you are guaranteed to ride the wave back up… And get this: SNDY is trading below its 50 DMA of .0393; by my calculations that presents upside opportunity of more than 78%.
There’s a catalyst too; one so big I expect that SNDY could rip a hole through resistance if it gets a solid break in the next session. The company’s just announce a projected 20% increase in sales for Q4.
Check out the chart…
Here’s a link to the chart: http://www.barchart.com/interactive_charts/stocks/SNDY
About
SNDY (Solos Endoscopy, Inc.) is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
Medical Device Market Will Reach $398 Billion In Two Years
A new report by Visiongain predicts the global medical devices market will reach $398 billion in 2017. That industry generated $321 billion in 2012, and its revenues will show strong growth to 2023.
The medical devices industry will witness significant opportunities for growth in the coming decade. Visiongain believes that market expansion will be driven by the introduction of innovative devices into the market and also by the demand generated by illnesses associated with the aging global population.
Cardiac and respiratory diseases generally affect people above the age of 65, and with the global over-65 population expected to rise up to 1 billion by 2020, devices used in the treatment of age-related illnesses will see significant growth in their revenues.
In 2012, the top twelve companies in the medical devices industry controlled 45.9% of the global market. This dominance is however being challenged by companies with intentions to enter the medical devices market. Samsung, for example, has been implementing a growth through acquisition strategy in order to compete with other leading electronic companies who have also recently invested in the medical devices market.
News Development
Solos Endoscopy Sales Increase by 20% for First Quarter 2016
SNDY recently announced that the Company expects to show a sales increase of more than 20% as compared to the fourth quarter of last year when it posts its first quarter financials for period ended March 31, 2016.
Solos Endoscopy's sales increased from $65,917.66 for the quarter ending December 31, 2015 to $79,622.89 for the first quarter of this year. This was accomplished without any increase in its current pricing structure or negative impact on its margins. Solos management expects the positive trend to continue as the demand for endoscopic instruments has been increasing worldwide.
The industry has developed several new modifications to its endoscopic instrument lines to accommodate the continual advances in laparoscopic surgical procedures. The significant advances over the past several years have led to a number of advantages to the patient with laparoscopic surgery versus an open procedure (laparotomy). The demand for endoscope services is increasing due to an increase in the aging and chronically ill population coupled with the expansion of medical procedures utilizing minimally invasive techniques. Advancements in endoscopic technologies and inclusion of various types of scopes, light sources, video cameras, real-time conversion of data into three-dimensional images are also driving this market.
To learn more about SNDY please visit their website: http://www.solosendoscopy.com/
SNDY is in an excellent position where the bounce opportunity is huge. Make your move now.
Sincerely,
